Quest Diagnostics (DGX) Share-based Compensation (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Share-based Compensation data on file, last reported at $20.0 million in Q1 2026.

• Quarterly Share-based Compensation fell 9.09% year-over-year to $20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.0 million (down 2.27% YoY) and the FY2025 annual result came in at $88.0 million, changed 0.0% from the prior year.
• Share-based Compensation retreated to $20.0 million in Q1 2026 per DGX's latest filing, from $25.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $27.0 million in Q4 2024, with the low at $16.0 million in Q2 2023.
• Average Share-based Compensation over 5 years is $20.6 million, with a median of $20.0 million recorded in 2024.
• Year-over-year, Share-based Compensation slipped 15.79% in 2023 and surged 42.11% in 2024.
• Quest Diagnostics' Share-based Compensation stood at $22.0 million in 2022, then slipped by 13.64% to $19.0 million in 2023, then surged by 42.11% to $27.0 million in 2024, then fell by 7.41% to $25.0 million in 2025, then dropped by 20.0% to $20.0 million in 2026.
• Business Quant data shows DGX's Share-based Compensation at $20.0 million in Q1 2026, $25.0 million in Q4 2025, and $20.0 million in Q3 2025.